Sign Up to like & get
recommendations!
1
Published in 2020 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-020-02675-9
Abstract: Simultaneous induction of tumor antigen-specific cytotoxic T lymphocytes (CTLs) and helper T lymphocytes (HTLs) is required for an optimal anti-tumor immune response. WT1 332 , a 16-mer WT1-derived helper peptide, induce HTLs in an HLA…
read more here.
Keywords:
peptide;
wt1 specific;
wt1 ctl;
wt1 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Cytotherapy"
DOI: 10.1016/j.jcyt.2019.03.352
Abstract: Background & Aim WT1 is highly expressed in many malignancies including leukemia and targeting WT1 as a Tumor Associated Antigen (TAA) in cancer immunotherapy is attractive. In this study, we induced WT1-specific cytotoxic T lymphocytes…
read more here.
Keywords:
activated cells;
specific ctls;
antigen;
wt1 specific ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Oncotarget"
DOI: 10.18632/oncotarget.26338
Abstract: In immunotherapy by cancer antigen-derived peptide vaccine, vaccination of cytotoxic T lymphocyte (CTL) peptide alone is common, while it remains unclear whether the addition of helper peptide vaccine to the CTL peptide vaccine is of…
read more here.
Keywords:
cd8;
wt1 specific;
wt1;
ctl ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms20030482
Abstract: Wilms tumor protein-1 (WT1) is an attractive target for adoptive T-cell therapy due to its expression in solid tumors and hematologic malignancies. However, T cells recognizing WT1 occur in low frequencies in the peripheral blood…
read more here.
Keywords:
wt1 specific;
specific cell;
specific cells;
heme oxygenase ... See more keywords